Savant Capital, LLC Johnson & Johnson Transaction History

Savant Capital, LLC

$11.7 Billion
Q3 2024

A detailed history of Savant Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Savant Capital, LLC holds 247,527 shares of JNJ stock, worth $37.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

247,527

Previous 231,407 6.97%

Holding current value

$37.9 Million

Previous $33.8 Million 18.6%

% of portfolio

0.34%

Previous 0.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$145.48 - $167.38 $2.35 Million - $2.7 Million	16,120 Added 6.97%	247,527 $40.1 Million
Q2 2024 Aug 05, 2024	BUY	$144.38 - $157.78 $1.09 Million - $1.2 Million	7,582 Added 3.39%	231,407 $33.8 Million
Q1 2024 May 03, 2024	BUY	$155.22 - $162.74 $1.02 Million - $1.07 Million	6,572 Added 3.03%	223,825 $35.4 Million
Q4 2023 Feb 05, 2024	SELL	$145.6 - $158.88 $1.24 Million - $1.35 Million	-8,500 Reduced 3.77%	217,253 $34.1 Million
Q3 2023 Nov 06, 2023	SELL	$155.75 - $174.48 $3.95 Million - $4.42 Million	-25,353 Reduced 10.1%	225,753 $35.2 Million
Q2 2023 Aug 04, 2023	BUY	$154.35 - $166.11 $8.94 Million - $9.63 Million	57,950 Added 30.0%	251,106 $41.6 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $3.02 Million - $3.6 Million	19,996 Added 11.55%	193,156 $29.9 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $554 Million - $622 Million	-3,456,967 Reduced 95.23%	173,160 $30.6 Million
Q4 2022 Feb 06, 2023	BUY	$160.2 - $179.79 $575 Million - $645 Million	3,588,251 Added 8568.75%	3,630,127 $641 Million
Q3 2022 Oct 28, 2022	SELL	$161.33 - $179.52 $66,951 - $74,500	-415 Reduced 0.98%	41,876 $6.84 Million
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $761,227 - $841,881	4,526 Added 11.98%	42,291 $7.51 Million
Q1 2022 May 05, 2022	BUY	$158.14 - $179.59 $108,167 - $122,839	684 Added 1.84%	37,765 $6.69 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $99,639 - $110,553	639 Added 1.75%	37,081 $6.34 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $90,278 - $100,323	559 Added 1.56%	36,442 $5.89 Million
Q2 2021 Aug 04, 2021	SELL	$159.48 - $171.07 $86,757 - $93,062	-544 Reduced 1.49%	35,883 $5.91 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $155,212 - $172,866	1,014 Added 2.86%	36,427 $5.99 Million
Q4 2020 Feb 03, 2021	SELL	$137.11 - $157.38 $226,917 - $260,463	-1,655 Reduced 4.46%	35,413 $5.57 Million
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $5,334 - $5,845	38 Added 0.1%	37,068 $5.52 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $332,329 - $401,215	2,580 Added 7.49%	37,030 $5.21 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $231,615 - $320,915	2,084 Added 6.44%	34,450 $4.52 Million
Q4 2019 Jan 31, 2020	BUY	$127.5 - $146.44 $152,362 - $174,995	1,195 Added 3.83%	32,366 $4.72 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $59,158 - $66,237	-466 Reduced 1.47%	31,171 $4.03 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $51,541 - $56,686	393 Added 1.26%	31,637 $4.41 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $2,388 - $2,656	-19 Reduced 0.06%	31,244 $4.37 Million
Q4 2018 Feb 05, 2019	BUY	$122.84 - $147.84 $98,394 - $118,419	801 Added 2.63%	31,263 $4.03 Million
Q3 2018 Oct 23, 2018	BUY	$121.58 - $142.88 $36,474 - $42,864	300 Added 0.99%	30,462 $4.21 Million
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $8,596 - $9,486	72 Added 0.24%	30,162 $3.66 Million
Q1 2018 Apr 27, 2018	SELL	$125.1 - $148.14 $110,963 - $131,400	-887 Reduced 2.86%	30,090 $3.86 Million
Q4 2017 Jan 31, 2018	BUY	$131.22 - $143.62 $132,400 - $144,912	1,009 Added 3.37%	30,977 $4.33 Million
Q3 2017 Oct 31, 2017	BUY	$129.47 - $135.38 $3.88 Million - $4.06 Million	29,968	29,968 $3.9 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Johnson & Johnson Transaction History